Cargando…
Trial Watch: Adoptive cell transfer immunotherapy
During the last two decades, several approaches for the activation of the immune system against cancer have been developed. These include rather unselective maneuvers such as the systemic administration of immunostimulatory agents (e.g., interleukin-2) as well as targeted interventions, encompassing...
Autores principales: | Galluzzi, Lorenzo, Vacchelli, Erika, Eggermont, Alexander, Fridman, Wolf Herve´, Galon, Jerome, Sautès-Fridman, Catherine, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382856/ https://www.ncbi.nlm.nih.gov/pubmed/22737606 http://dx.doi.org/10.4161/onci.19549 |
Ejemplares similares
-
Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013) -
Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Aranda, Fernando, et al.
Publicado: (2014) -
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012) -
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012) -
Trial watch: Peptide vaccines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012)